7725 Stock Overview
LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
LabTurbo Biotech Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$32.25 |
52 Week High | NT$39.90 |
52 Week Low | NT$27.00 |
Beta | 0 |
1 Month Change | -7.33% |
3 Month Change | -2.71% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -19.17% |
Recent News & Updates
Recent updates
Shareholder Returns
7725 | TW Medical Equipment | TW Market | |
---|---|---|---|
7D | -3.7% | 2.7% | 1.3% |
1Y | n/a | 4.9% | 29.2% |
Return vs Industry: Insufficient data to determine how 7725 performed against the TW Medical Equipment industry.
Return vs Market: Insufficient data to determine how 7725 performed against the TW Market.
Price Volatility
7725 volatility | |
---|---|
7725 Average Weekly Movement | 5.5% |
Medical Equipment Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in TW Market | 8.7% |
10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 7725 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 7725's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | n/a | n/a | labturbo.com |
LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.
LabTurbo Biotech Corporation Fundamentals Summary
7725 fundamental statistics | |
---|---|
Market cap | NT$1.56b |
Earnings (TTM) | NT$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 7725 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7725 income statement (TTM) | |
---|---|
Revenue | NT$0 |
Cost of Revenue | NT$0 |
Gross Profit | NT$0 |
Other Expenses | NT$0 |
Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 7725 perform over the long term?
See historical performance and comparison